PSA screening reduces prostate cancer mortality over 15 years, Finds new randomized clinical trial
UK: A groundbreaking study has unveiled promising insights into the efficacy of Prostate-Specific Antigen (PSA) screening in reducing prostate cancer mortality over 15 years. The study published in the Journal of the American Medical Association (JAMA) is …